| JXHS2100004 | 乌帕替尼缓释片 | upadacitinib | Tablet, extended release | Chemical Drugs(2.4) | Import Drug Application | 2021-01-13 | 艾伯维医药贸易（上海）有限公司 | AbbVie Pharmaceutical Trading (Shanghai) Co Ltd;Abbvie Deutschland Gmbh & Co KG;Abbvie Ireland Nl BV | In Review | 2021-01-12 | view |
| JXHS2000188 | 乌帕替尼缓释片 | upadacitinib | Tablet, extended release | Chemical Drugs(5.1) | Import Drug Application | 2021-01-01 | 艾伯维医药贸易（上海）有限公司 | AbbVie Pharmaceutical Trading (Shanghai) Co Ltd;Abbvie Deutschland Gmbh & Co KG;Abbvie Ireland Nl BV | In Review | 2021-01-01 | view |
| JXHS2000186 | 乌帕替尼缓释片 | upadacitinib | Tablet, extended release | Chemical Drugs(2.4) | Import Drug Application | 2020-12-28 | 艾伯维医药贸易（上海）有限公司 | AbbVie Pharmaceutical Trading (Shanghai) Co Ltd;Abbvie Deutschland Gmbh & Co KG;Abbvie Ireland Nl BV | In Review | 2020-12-25 | view |
| JXHS2000187 | 乌帕替尼缓释片 | upadacitinib | Tablet, extended release | Chemical Drugs(2.4) | Import Drug Application | 2020-12-28 | 艾伯维医药贸易（上海）有限公司 | AbbVie Pharmaceutical Trading (Shanghai) Co Ltd;Abbvie Deutschland Gmbh & Co KG;Abbvie Ireland Nl BV | In Review | 2020-12-25 | view |
| CYHS2501221 | 乌帕替尼缓释片 | upadacitinib | Tablet, extended release | Chemical Drugs(4) | Generic Drug | 2025-03-28 | | Fosun Wanbang (Jiangsu) Pharmaceutical Group Co Ltd | | | view |
| JYHB2400026 | 乌帕替尼缓释片 | upadacitinib | Tablet, extended release | Chemical Drugs(2.4) | Supplementary Application | 2024-01-19 | | Abbvie Deutschland Gmbh & Co KG;Abbvie Ireland Nl BV | | | view |
| JTH2100663 | 乌帕替尼缓释片 | upadacitinib | Tablet, extended release | Chemical Drugs | Disposable Import Drug Application | 2021-09-29 | | AbbVie Pharmaceutical Trading (Shanghai) Co Ltd;Abbvie Deutschland Gmbh & Co KG;Abbvie Ireland Nl BV | | | view |
| JYHB2400547 | 乌帕替尼缓释片 | upadacitinib | Tablet, extended release | Chemical Drugs(2.4) | Supplementary Application | 2024-10-13 | | Abbvie Deutschland Gmbh & Co KG;Abbvie Ireland Nl BV | | | view |
| CYHS2404262 | 乌帕替尼缓释片 | upadacitinib | Tablet, extended release | Chemical Drugs(4) | Generic Drug | 2024-12-10 | | Shandong Qidu Pharmaceutical Co Ltd | | | view |
| JYHB2200410 | 乌帕替尼缓释片 | upadacitinib | Tablet, extended release | Chemical Drugs(2.4) | Supplementary Application | 2022-08-01 | | Abbvie Deutschland Gmbh & Co KG;Abbvie Ireland Nl BV | | | view |
| CYHS2400083 | 乌帕替尼缓释片 | upadacitinib | Tablet, extended release | Chemical Drugs(4) | Generic Drug | 2024-01-06 | | Hinye Pharmaceutical Co Ltd | | | view |
| CYHS2501172 | 乌帕替尼缓释片 | upadacitinib | Tablet, extended release | Chemical Drugs(4) | Generic Drug | 2025-03-25 | | Shanghai Sine Promod Pharmaceutical Co Ltd | | | view |
| JYHB2400545 | 乌帕替尼缓释片 | upadacitinib | Tablet, extended release | Chemical Drugs(2.4) | Supplementary Application | 2024-10-13 | | Abbvie Deutschland Gmbh & Co KG;Abbvie Ireland Nl BV | | | view |
| CYHS2501433 | 乌帕替尼缓释片 | upadacitinib | Tablet, extended release | Chemical Drugs(4) | Generic Drug | 2025-04-15 | | Beijing Foyou Pharma Co Ltd | | | view |
| JXHS2200006 | 乌帕替尼缓释片 | upadacitinib | Tablet, extended release | Chemical Drugs(2.4) | Import Drug Application | 2022-01-07 | | AbbVie Pharmaceutical Trading (Shanghai) Co Ltd;Abbvie Deutschland Gmbh & Co KG;Abbvie Ireland Nl BV | | | view |
| CYHS2404275 | 乌帕替尼缓释片 | upadacitinib | Tablet, extended release | Chemical Drugs(4) | Generic Drug | 2024-12-10 | | Chongqing Huapont Pharmaceutical Co Ltd | | | view |
| JXHS2200007 | 乌帕替尼缓释片 | upadacitinib | Tablet, extended release | Chemical Drugs(2.4) | Import Drug Application | 2022-01-07 | | AbbVie Pharmaceutical Trading (Shanghai) Co Ltd;Abbvie Deutschland Gmbh & Co KG;Abbvie Ireland Nl BV | | | view |
| JXHS2300008 | 乌帕替尼缓释片 | upadacitinib | Tablet, extended release | Chemical Drugs(5.1) | Import Drug Application | 2023-01-09 | | Abbvie Deutschland Gmbh & Co KG;Abbvie Ireland Nl BV | | | view |
| CYHS2500617 | 乌帕替尼缓释片 | upadacitinib | Tablet, extended release | Chemical Drugs(4) | Generic Drug | 2025-02-07 | | Visum Pharmaceutical Co Ltd | | | view |
| JYHB2400165 | 乌帕替尼缓释片 | upadacitinib | Tablet, extended release | Chemical Drugs(2.4) | Supplementary Application | 2024-04-16 | | Abbvie Deutschland Gmbh & Co KG;Abbvie Ireland Nl BV | | | view |
